Julianne buys BMRN 62.41: Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma
Investor-Edge has initiated coverage on the following equities: BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Amgen Inc. (NASDAQ: AMGN) and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free technical research ... ...
39 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home